| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.094 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |